Ignite Creation Date:
2025-12-26 @ 11:14 AM
Ignite Modification Date:
2025-12-31 @ 7:13 PM
Study NCT ID:
NCT03366428
Status:
COMPLETED
Last Update Posted:
2022-04-12
First Post:
2017-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2-Expressing Breast Cancer
Sponsor:
Daiichi Sankyo Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-26
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-19
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-04
First Submit QC Date:
None
Study First Post Date:
2017-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-05-17
Results First Submit QC Date:
None
Results First Post Date:
2021-06-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-17
Last Update Post Date:
2022-04-12
Last Update Post Date Type:
ACTUAL